- In August, the
company agreed to
acquire ChemoCentryx for $3.7 billion in an all-cash deal.
ChemoCentryx is the
maker of Tavneos—a drug
treatment for...
- acknowledged. "
ChemoCentryx Announces Approval in ****an of
Tavneos (Avacopan) for the
Treatment of ANCA-****ociated Vasculitis".
ChemoCentryx, Inc. (Press...
- 1016/j.lpm.2013.02.256. "
ChemoCentryx Announces FDA
Approval of
Tavneos (avacopan) in ANCA-****ociated Vasculitis".
ChemoCentryx, Inc. (Press release). 8...
-
partnered with
biotechs such as Akebia,
Angion Biomedica, Cara Therapeutics,
ChemoCentryx and
Travere Therapeutics. CSL
Vifor is
present in
North and
South America...
-
Depot 291 4
Check Point Software Technologies 225 5
Delta Star 214 6
ChemoCentryx Inc. 182 7 Joby Aero Inc. 170 8
Allakos Inc. 163 9
Atreca Inc. 140 10...
-
April 2017. "
ChemoCentryx Identifies Novel Small Molecule ChemR23
Antagonist for the
Treatment of
Inflammatory Diseases".
ChemoCentryx. 2010-04-10. Archived...
- a
director of Alta Partners. He
serves on the
board of
directors for
ChemoCentryx,
Immune Design, Metabolex, and Scynexis. He was a co-founder of Chiron...
- "3-(imidazolyl)-pyrazolo[3,4-b]pyridines",
published 2009-12-08, ****igned to
ChemoCentryx Inc.
Triggle DJ (1997).
Dictionary of
pharmacological agents. London:...
-
Herzlinger has
served as
director or
board member of Bard,
Cardinal Health,
ChemoCentryx, HCR
Manor Care, HealthAllies.com, John Deere,
Lumenos (now
Anthem Inc...
